Lynparza® (olaparib)
for Ovarian Cancer

Lynparza (olaparib) is a targeted therapy used to treat certain types of ovarian, breast, fallopian tube, pancreatic, prostate, and peritoneal cancers, particularly those with BRCA1, BRCA2, HRR, or HER2-negative genetic markers. It belongs to a class of medicines called PARP inhibitors, which block the PARP protein that cancer cells rely on for DNA repair. By preventing this repair, Lynparza helps stop cancer cells from surviving and multiplying.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Ovarian Cancer